Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer

BACKGROUND: Vaccine treatment using multiple peptides derived from multiple proteins is considered to be a promising option for cancer immune therapy, but scientific evidence supporting the therapeutic efficacy of multiple peptides is limited. METHODS: We conducted phase I trials using a mixture of...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hiroyuki, Fukuhara, Mitsuro, Yamaura, Takumi, Mutoh, Satoshi, Okabe, Naoyuki, Yaginuma, Hiroshi, Hasegawa, Takeo, Yonechi, Atsushi, Osugi, Jun, Hoshino, Mika, Kimura, Takashi, Higuchi, Mitsunori, Shio, Yutaka, Ise, Kazuya, Takeda, Kazuyoshi, Gotoh, Mitsukazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639131/
https://www.ncbi.nlm.nih.gov/pubmed/23578144
http://dx.doi.org/10.1186/1479-5876-11-97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639131/
https://www.ncbi.nlm.nih.gov/pubmed/23578144
http://dx.doi.org/10.1186/1479-5876-11-97

Ejemplares similares